E. Sijbrands

Publications371
h-index70
Citations28,045
Highly Influential Citations1,002
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Hofman
  • 2,032 Publications • 156,706 Citations
  • J. Kastelein
  • 650 Publications • 65,025 Citations
  • M. McCarthy
  • 966 Publications • 133,968 Citations
  • A. Uitterlinden
  • 1,211 Publications • 129,368 Citations
  • Publications
  • Influence
Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids
Plasma concentrations of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides are among the most important risk factors for coronary artery… Expand
  • 3,119
  • 166
  • PDF
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we conducted a meta-analysis of genetic variants on the Metabochip, including 34,840 cases and… Expand
  • 1,629
  • 81
  • PDF
Genome-wide association study of blood pressure and hypertension
Blood pressure is a major cardiovascular disease risk factor. To date, few variants associated with interindividual blood pressure variation have been identified and replicated. Here we report… Expand
  • 1,253
  • 74
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
By combining genome-wide association data from 8,130 individuals with type 2 diabetes (T2D) and 38,987 controls of European descent and following up previously unidentified meta-analysis signals in a… Expand
  • 1,650
  • 61
  • PDF
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
Recent genome-wide association (GWA) studies of lipids have been conducted in samples ascertained for other phenotypes, particularly diabetes. Here we report the first GWA analysis of loci affecting… Expand
  • 854
  • 35
  • PDF
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
BACKGROUND Ezetimibe, a cholesterol-absorption inhibitor, reduces levels of low-density lipoprotein (LDL) cholesterol when added to statin treatment. However, the effect of ezetimibe on the… Expand
  • 837
  • 23
  • PDF
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance
Recent genome-wide association studies have described many loci implicated in type 2 diabetes (T2D) pathophysiology and β-cell dysfunction but have contributed little to the understanding of the… Expand
  • 661
  • 23
  • PDF
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Objective To determine the efficacy of statin treatment on risk of coronary heart disease in patients with familial hypercholesterolaemia. Design Cohort study with a mean follow-up of 8.5 years.… Expand
  • 569
  • 22
  • PDF
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
To further understanding of the genetic basis of type 2 diabetes (T2D) susceptibility, we aggregated published meta-analyses of genome-wide association studies (GWAS), including 26,488 cases and… Expand
  • 806
  • 19
  • PDF
Variants in MTNR1B influence fasting glucose levels
To identify previously unknown genetic loci associated with fasting glucose concentrations, we examined the leading association signals in ten genome-wide association scans involving a total of… Expand
  • 676
  • 19
  • PDF
...
1
2
3
4
5
...